CV2/CRMP5-antibody-related paraneoplastic optic neuropathy associated with small-cell lung cancer

16Citations
Citations of this article
30Readers
Mendeley users who have this article in their library.

Abstract

A 61-year-old woman who had smoked for 41 years developed subacute dizziness, ataxic gait, opsoclonus, and right visual impairment. She had right optic disc swelling and optic nerve gadolinium enhancement on magnetic resonance imaging. She had small-cell lung cancer (SCLC), with CV2/collapsin response mediator protein (CRMP)5 and HuD antibodies in her serum and cerebrospinal fluid. She was diagnosed with paraneoplastic optic neuropathy (PON) accompanied by paraneoplastic opsoclonus-ataxia syndrome. Her symptoms improved after removing the SCLC. Classical PON is rare in Japan. We recommend assaying for CV2/ CRMP5 antibodies and searching for cancer in elderly patients with subacute painless visual impairment.

Cite

CITATION STYLE

APA

Nakajima, M., Uchibori, A., Ogawa, Y., Miyazaki, T., Ichikawa, Y., Kaneko, K., … Chiba, A. (2018). CV2/CRMP5-antibody-related paraneoplastic optic neuropathy associated with small-cell lung cancer. Internal Medicine, 57(11), 1645–1649. https://doi.org/10.2169/internalmedicine.9736-17

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free